awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37924294-444567B7-6507-4EB9-98A1-E439DCEA88A0
Q37924294-444567B7-6507-4EB9-98A1-E439DCEA88A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37924294-444567B7-6507-4EB9-98A1-E439DCEA88A0
Challenges and opportunities in developing novel drugs for TB.
P2860
Q37924294-444567B7-6507-4EB9-98A1-E439DCEA88A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37924294-444567B7-6507-4EB9-98A1-E439DCEA88A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a4a6951984de598d743b10cc2db6ac9bcc6d256
P2860
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts